Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

[68Ga]CBP8 PET/MRI

Phase 3

BBrigham and Women's Hospital

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Cardiac AmyloidosisActive, not recruiting

Cardiac AmyloidosisPhase 3

Active, not recruiting

Timeline

Expected Milestones

Q4 2026

Phase 3Active, not recruiting

Cardiac Amyloidosis

NCT05619302

Clinical

Trials by Indication[1]

Cardiac Amyloidosis1 trial

Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis

Active, not recruiting·BBrigham and Women's Hospital·Phase 3·NCT05619302·18 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for [68Ga]CBP8 PET/MRI. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for [68Ga]CBP8 PET/MRI. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Brigham and Women's Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: BBrigham and Women's Hospital

Related News